WUSA9 | April 8, 2022
“It’s been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it,” said Lawrence Gostin, a Professor of Global Health Law at Georgetown University.
WUSA9 | April 8, 2022
“It’s been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it,” said Lawrence Gostin, a Professor of Global Health Law at Georgetown University.
Press Release
September 27, 2023
In The News
September 25, 2023
In The News
September 25, 2023